Facetten
Zugriff
Einrichtung
Medientyp
- Text 8
Karte
Erscheinungsjahr
Autor/in
- Besemer, Britta
- Bertsch, Uta 3
- Hänel, Mathias 3
- Mai, Elias K 3
- Duerig, Jan 2
- alle zeigen
Sprache
- Englisch 8
8 Einträge gefunden
-
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment:Results from the Phase 2 GMMG-DANTE Trial
- Leypoldt, Lisa B
- Gavriatopoulou, Maria
- Besemer, Britta
- Salwender, Hans
- Raab, Marc S
- Nogai, Axel
- Khandanpour, Cyrus
-
Isatuximab, Carfilzomib, Lenalidomid und Dexamethason (Isa-KRd) in der Erstlinientherapie des Hochrisiko Multiplen Myeloms: Interimanalyse der GMMG-CONCEPT Studie, Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
- Leypoldt, Lisa B.
- Besemer, Britta
- Asemissen, Anne Marie
- Hänel, Mathias
- Blau, Igor Wolfgang
- Görner, Martin
- Ko, Yon-Dschun
-
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
- Goldschmidt, Hartmut
- Mai, Elias K
- Bertsch, Uta
- Fenk, Roland
- Nievergall, Eva
- Tichy, Diana
- Besemer, Britta
-
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
- Klein, Eva-Maria
- Tichy, Diana
- Salwender, Hans J
- Mai, Elias K
- Duerig, Jan
- Weisel, Katja C
- Benner, Axel
-
-
-
-